Artículos de revistas
Neuromuscular And Cardiovascular Effects Of Pipecuronium. A Comparative Study Between Different Doses [efeitos Neuromusculares E Cardiovasculares Do Pipecurônio. Estudo Comparativo Entre Diferentes Doses]
Registro en:
Revista Brasileira De Anestesiologia. , v. 58, n. 6, p. 582 - 592, 2008.
347094
10.1590/S0034-70942008000600003
2-s2.0-56849085254
Autor
Braga A.D.F.D.A.
Yoshioka L.
Braga F.S.D.S.
Poterio G.M.B.
Frias J.A.F.
Rodrigues R.D.C.
Institución
Resumen
BACKGROUND AND OBJECTIVES: Pipecuronium is a non-depolarizing neuromuscular blocker with similar properties to pancuronium, but without cardiovascular effects. Neuromuscular effects, conditions of tracheal intubation, and hemodynamic repercussions of two different doses of pipecuronium were evaluated. METHOD: Patients were divided into two groups according to the dose of pipecuronium: Group I (0.04 mg.kg-1) and Group II (0.05 mg.kg -1). Intramuscular midazolam (0.1 mg.kg-1) was administered 30 minutes before the surgery. Propofol (2.5 mg.kg-1), preceded by fentanyl (5 μg.kg-1) and pipecuronium (0.04 and 0.05 mg.kg-1 for Groups I and II, respectively), was administered for anesthetic induction. Patients were ventilated with 100% oxygen via a face mask until a 75% reduction in the amplitude of the response to an isolated stimulus (1 Hz) is achieved, at which time laryngoscopy and intubation were carried out. Anesthetic maintenance was achieved with isoflurane (0.5 to 1%) with a mixture of 50% O2 and N2O. Mechanical ventilation was used to maintain PETCO2 between 32 and 36 mmHg. The pharmacodynamics of pipecuronium was evaluated by acceleromyography. RESULTS: Mean times and standard deviation for the onset of action, clinical duration (T125%), and recovery index (T125-75%) were: Group I (122.10 ± 4.18 sec, 49.63 ± 9.54 min, and 48.21 ± 6.72 min), and Group II (95.78 ± 8.91 sec, 64.84 ± 13.13 min, and 48.52 ± 4.95 min). Onset of action, clinical duration, and conditions of tracheal intubation were significantly different for both groups. CONCLUSIONS: Pipecuronium at a dose of 0.05 mg.kg-1 can be used in prolonged procedures in which cardiovascular changes should be avoided. © Sociedade Brasileira de Anestesiologia, 2008. 58 6 582 592 Diefenbach, C., Mellinghoff, H., Buzello, W., Variability of pipecuronium neuromuscular blockade (1993) Acta Anaesthesiol Scand, 37, pp. 189-191 Larijani, G.E., Bartkowski, R.R., Azad, S.S., Clinical pharmacology of pipecuronium bromide (1989) Anesth Analg, 68, pp. 734-739 Pittet, J.F., Tassonyi, E., Morel, D.R., Pipecuronium-induced neuromuscular blockade during nitrous oxide-fentanyl, isoflurane, and halothane anesthesia in adults and children (1989) Anesthesiology, 71, pp. 210-213 Boros, M., Szenohradszky, J., Kertesz, A., Clinical experiences with pipecuronium bromide (1983) Acta Chir Hung, 24, pp. 207-214 Melloni C, Clinical pharmacology of pipecuronium a comparative study of its duration of action in balanced anesthesia (propofol/ fentanyl) vs isoflurane. Minerva Anestesiol, 1995;61: 491-500Sanfilippo, M., Fierro, G., Vilardi, V., Clinical evaluation of different doses of pipecuronium bromide during nitrous-oxidefentanyl anaesthesia in adult surgical patients (1992) Eur J Anaesthesiol, 9, pp. 49-53 Wierda, J.M., Richardson, F.J., Agoston, S., Dose-response relation and time course of action of pipecuronium bromide in humans anesthetized with nitrous oxide and isoflurane, halothane, or droperidol and fentanyl (1989) Anesth Analg, 68, pp. 208-213 Atherton, D.P., Hunter, J.M., Clinical pharmacokinetics of the newer neuromuscular blocking drugs (1999) Clin Pharmacokinet, 36, pp. 169-189 Foldes, F.F., Nagashima, H., Nguyen, H.D., Neuromuscular and cardiovascular effects of pipecuronium (1990) Can J Anaesth, 37, pp. 549-555 Denman, W.T., Goudsouzian, N.G., Gelb, C., Comparison of neuromuscular, cardiovascular, and histamine-releasing properties of doxacurium and pipecuronium (1996) J Clin Anesth, 8, pp. 113-118 Mallampati, S.R., Gatt, S.P., Gugino, L.D., A clinical sign to predict difficult tracheal intubation: A prospective study (1985) Can Anaesth Soc J, 32, pp. 429-434 Goldberg, M.E., Larijani, G.E., Azad, S.S., Comparison of tracheal intubating conditions and neuromuscular blocking profiles after intubating doses of mivacurium chloride or succinylcholine in surgical outpatients (1989) Anesth Analg, 69, pp. 93-99 Donati, F., Onset of action of relaxants (1988) Can J Anaesth, 35, pp. S52-S58 Iwasaki, H., Igarashi, M., Yamauchi, M., The effect of cardiac output on the onset of neuromuscular block by vecuronium (1995) Anaesthesia, 50, pp. 361-362 Kopman, A.F., Molar potency and the onset of action of rocuronium (1994) Anesth Analg, 78, pp. 815-816 Puhringer, F.K., Mitterschiffthaler, G., Khuenl-Brady, K.S., The onset of pipecuronium following application of the priming principle (1996) Eur J Anaesthesiol, 13, pp. 478-482 Canga, J.C., Lehn, C.N., Tonelli, D., Efeito do priming na redução da latência do pipecurônio, novo bloqueador neuromuscular não-despolarizante. (2005) Rev Bras Anestesiol, 55, pp. 381-386 Ueda, N., Masuda, Y., Muteki, T., Dose-response relation and time course of action of pipecuronium in patients anesthetized with nitrous oxide and sevoflurane (1993) J Anesth, 7, pp. 151-156 Stanley, J.C., Mirakhur, R.K., Bell, P.F., Neuromuscular effects of pipecuronium bromide (1991) Eur J Anaesthesiol, 8, pp. 151-156 Caldwell, J.E., Castagnoli, K.P., Canfell, P.C., Pipecuronium and pancuronium: Comparison of pharmacokinetics and duration of action (1988) Br J Anaesth, 61, pp. 693-697 Viby-Mogensen, J., Engbaek, J., Eriksson, L.I., Good clinical research practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents (1996) Acta Anaesthesiol Scand, 40, pp. 59-74 England, A.J., Wu, X., Richards, K.M., The influence of cold on the recovery of three neuromuscular blocking agents in man (1996) Anaesthesia, 51, pp. 236-240 Gencarelli, P.J., Swen, J., Koot, H.W., The effects of hypercarbia and hypocarbia on pancuronium and vecuronium neuromuscular blockades in anesthetized humans (1983) Anesthesiology, 59, pp. 376-380 Braga, A.F.A., Potério, G.M.B., Braga, F.S.S., Influência do sevoflurano e do isoflurano na duração do bloqueio neuromuscular produzido pelo rocurônio. (2001) Rev Bras Anestesiol, 51, pp. 2-9 Braga, A.F.A., Braga, F.S.S., Potério, G.M.B., Influência do sevoflurano e do isoflurano na recuperação do bloqueio neuromuscular produzido pelo cisatracúrio. (2002) Rev Bras Anestesiol, 52, pp. 517-524 Cardoso, L.S.M., Martins, C.R., Tardelli, M.A., Efeitos da lidocaína por via venosa sobre a farmacodinâmica do rocurônio. (2005) Rev Bras Anestesiol, 55, pp. 371-380 Smith, D.C., Booth, J.V., Influence of muscle temperature and forearm position on evoked electromyography in the hand (1994) Br J Anaesth, 72, pp. 407-410 Miller, R.D., Way, W.L., Dolan, W.M., The dependence of pancuronium- and d-tubocurarine-induced neuromuscular blockades on alveolar concentrations of halothane and forane (1972) Anesthesiology, 37, pp. 573-581 Brett, R.S., Dilger, J.P., Yland, K.F., Isoflurane causes "flickering" of the acetylcholine receptor channel: Observations using the patch clamp (1988) Anesthesiology, 69, pp. 161-170 Vitez TS, Miller RD, Eger EI 2nd et al. - Comparison in vitro of isoflurane and halothane potentiation of d-tubocurarine and succinylcholine neuromuscular blockades. Anesthesiology, 1974 41:53-56Waud, B.E., Waud, D.R., The effects of diethyl ether, enflurane, and isoflurane at the neuromuscular junction (1975) Anesthesiology, 42, pp. 275-280 Williams, N.E., Webb, S.N., Calvey, T.N., Differential effects of myoneural blocking drugs on neuromuscular transmission (1980) Br J Anaesth, 52, pp. 1111-1115 Shanks CA, Pharmacokinetics of the nondepolarizing neuromuscular relaxants applied to calculation of bolus and infusion dosage regimens. Anesthesiology, 1986;64:72-86Fisher, D.M., Rosen, J.I., A pharmacokinetic explanation for increasing recovery time following larger or repeated doses of nondepolarizing muscle relaxants (1986) Anesthesiology, 65, pp. 286-291 Ginsberg, B., Glass, P.S., Quill, T., Onset and duration of neuromuscular blockade following high-dose vecuronium administration (1989) Anesthesiology, 71, pp. 201-205 Stanley, J.C., Carson, I.W., Gibson, F.M., Comparison of the haemodynamic effects of pipecuronium and pancuronium during fentanyl anaesthesia (1991) Acta Anaesthesiol Scand, 35, pp. 262-266 Sarner, J.B., Brandom, B.W., Dong, M.L., Clinical pharmacology of pipecuronium in infants and children during halothane anesthesia (1990) Anesth Analg, 71, pp. 362-366 Vizi, E.S., Kobayashi, O., Torocsik, A., Heterogeneity of presynaptic muscarinic receptors involved in modulation of transmitter release (1989) Neuroscience, 31, pp. 259-267 Kerr, W.J., Baird, W.L., Clinical studies on Org NC 45: Comparison with pancuronium (1982) Br J Anaesth, 54, pp. 1159-1165